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Dietary Fat Composition Inﬂuences Tissue Lipid Proﬁle and Gene
Expression in Fischer-344 Rats
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Abstract The AIN-76A diet causes fatty liver in rodents
when fed for long periods of time. The aim of this study was to
utilize fatty acid analysis and transcriptomics to investigate
the effects of different fat sources in the AIN-76A diet on
tissue lipid proﬁles and gene expression in male, weanling
Fischer-344 rats. Animals were fed isocaloric diets that differed only in the fat source: (1) corn oil (CO) (2) anhydrous
milk fat (AMF), and (3) AMF supplemented with 10 %
phospholipids from the milk fat globule membrane (AMFMFGM). There were no differences in food intake, body
weight, growth rate, or body fat composition among the
groups, and the fatty acid compositions of red blood cells
(RBC), plasma, muscle, and visceral adipose tissues reﬂected
the dietary fat sources. Modifying the fat source resulted in
293 genes differentially regulated in skeletal muscle, 1,124 in
adipose, and 831 in liver as determined by analysis of variance (ANOVA). Although tissue fatty acid proﬁles mostly
reﬂected the diet, there were several quantitative differences
in lipid classes in the liver and plasma. The AMF diet resulted
in the highest level of hepatic triacylglycerols, but the lowest
level in plasma. The CO diet resulted in signiﬁcant accumulation of hepatic unesteriﬁed fatty acids and decreased
DGAT expression and activity, a potential trigger for steatohepatitis. These results indicate that the fatty acid composition and presence of polar lipids in the AIN-76A diets

have signiﬁcant effects on lipid partitioning, gene expression,
and potentially the development of liver pathology.
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Introduction
The AIN-76 diet is a puriﬁed rodent diet that was developed in the late 1970s by an ad hoc committee formed by

the American Institute of Nutrition (AIN) [1]. One rationale for developing this diet was to provide researchers
with a nutritionally adequate diet that would allow for
standardizing studies between laboratories. Not long after
this diet was developed several groups reported undesirable
physiological effects linked to the diet, such as hemorrhagic deaths [2], nephrocalcinosis [3], and fatty liver [4].
An amended formulation of the diet (AIN-76A) was
developed in 1980 with an increased vitamin K content to
address the hemorrhagic effect [5]. In 1993 two revised
diets were formulated to replace the AIN-76A, a version
for growing animals (AIN-93G) and a maintenance formula for mature animals (AIN-93M). These revised diets
contained a higher calcium to phosphorus ratio (from 0.75
to 1.3) to prevent the nephrocalcinosis found in female rats
consuming the AIN-76A diet [1]. In addition, the carbohydrate composition was changed from 50 % sucrose and
15 % cornstarch in the AIN-76A formula to *40 %
cornstarch, 15 % dextrinized cornstarch, and 10 % sucrose
in the AIN-93G diet. This change represents a ﬁvefold
decrease in the fructose content of the diet and is not
associated with the accumulation of hepatic lipids caused
by long-term feeding of the high sucrose levels [6]. Despite
the availability of the improved rodent diets, the AIN-76A
still remains popular in speciﬁc research ﬁelds, such as in
studies investigating the effects of diet on colon cancer
using the aberrant crypt foci model (ACF). In fact, in a
database maintained to compare the efﬁcacy of diet modulation on the incidence of ACF, the overwhelming
majority of studies have utilized the AIN-76A [7].
The propensity of the AIN-76A diet to result in accumulation of hepatic lipids is potentially of interest to
human nutrition, as it is estimated that between 20 and
30 % of adults in Western countries have nonalcoholic
fatty liver disease (NAFLD) and this level rises to between
70 and 90 % in obese individuals and those with diabetes
[8]. To test the hypothesis that high levels of dietary
fructose are responsible for the accumulation of hepatic
lipids, Bacon et al. [9] tested the effects of modifying the
sucrose content of the AIN-76A diet in a 3-week feeding
study in rats. According to the results, diets containing
greater than 25 % sucrose resulted in signiﬁcantly higher
hepatic triacylglycerols (TAG) than ones with less than
20 % sucrose or chow.
We recently conducted an ACF study utilizing the AIN76A diet to investigate the potential chemopreventive
effects of a complex milk fat fraction [10]. In the study we
used three diets with different fat compositions: (1) corn oil
(CO), (2) anhydrous milk fat (AMF), and (3) anhydrous
milk fat supplemented with milk fat globule membrane
(AMF-MFGM). CO diet is the standard fat source for the
AIN-76A diet, and for the AMF diet, the 5 % mass of fat
was replaced with AMF. Formulation of the AMF-MFGM

diet was achieved by utilizing an isolate of MFGM (providing 10 % phospholipids of total fat) that was isolated
from cream, and which also contained protein, carbohydrate, and minerals in addition to the fat. The details of the
diet formulation have been reported previously [10].
MFGM is derived from the apical surface of mammary
epithelial cells and surrounds the fat droplets in milk [11]. It is
composed primarily of TAG, proteins, and phospholipids
(PL) [12]. The composition of the polar lipids of MFGM can
vary according to the method of isolation, but the major
constituents are phosphatidylcholine (*32 %), phosphatidylethanolamine (32 %), sphingomyelin (*24 %), phosphatidylinositol (*4 %), phosphatidylserine (*3 %), and
gangliosides (*3 %) [13]. A large amount of this material is
produced in the USA each year as a byproduct of butter
production, and is available as a food ingredient. Owing to its
unique lipid proﬁle and membrane protein proﬁle, MFGM
has been suggested as a potentially bioactive food ingredient
with novel nutritional functionalities [14]. Despite this supposition, few studies have been conducted in vivo with either
animal models or humans to evaluate the potential of this
material as a bioactive ingredient.
The goal of this study was to investigate lipid metabolism in rats fed a diet known to induce hepatic stress. Our
approach involved subjecting lipid-metabolizing tissues to
two different, yet comprehensive analytical techniques
(lipid and gene expression proﬁling) to understand how the
dietary fats affected the lipid metabolism.

Materials and Methods
Animals and Diets
Eleven animals used in this study were among a group of
63 male, weanling Fischer-344 rats (Charles River Laboratories) used in another study [10]. They were randomly
assigned to one of three isocaloric dietary treatments that
differed only in the fat source [10]. After a 7-day acclimation period on standard chow diets, the rats were individually housed in a room controlled for temperature,
humidity, and light cycle and were given free access to
experimental diets and deionized water. Food intake and
weight were measured weekly. All experimental protocols
involving animals were approved by the Utah State University Institutional Animal Care and Use Committee.
Animals were fed experimental diets for 12 weeks.
After MRI analysis of body composition (EchoMRI900TM), rats were killed by cardiac puncture following
ketamine/xylazine anesthesia. Liver, adipose, and skeletal
muscle tissues and blood samples were collected, ﬂash
frozen in liquid nitrogen, and stored at -80 oC for until the
time of analysis.

Lipid Extraction
Tissue samples were removed from the freezer and a
sample of tissue was cut into small pieces with a razor and
placed in a mortar with liquid nitrogen and ground to
obtain a ﬁne homogenous powder. About 200 mg of the
tissue powder or plasma from each sample was weighed
and put into a screw-capped glass tube. Surrogate standards, including sphingomyelin, phosphatidylcholine,
phosphatidylserine, phosphatidylethanolamine, diacylglycerol (DG), unesteriﬁed fatty acids (FFA), TAG, and cholesteryl esters (CE), were prepared in chloroform.
Surrogate standards (100 ll) for different lipid classes were
added to each sample and weights were recorded. Lipids
were extracted by the method of Folch et al. [15] with
slight modiﬁcations. Samples were mixed with 5 ml
chloroform/methanol (2:1 with butylated hydroxytoluene,
BHT). The whole mixture was sonicated and then agitated
for 15–20 min in an orbital shaker at room temperature.
The mixture was washed with 0.2 volumes (1 ml for 5 ml
solvent mixture) of 0.9 % NaCl solution and vortexed for
20 s. Subsequently, the mixture was centrifuged at
1,5009g for 10 min to separate the two phases. The lower
(chloroform) phase containing lipids was collected and
evaporated under a nitrogen stream and then reconstituted
in a small volume of hexane with BHT in a 4-ml amber vial
and stored at -80 oC until further analysis.
Separation and Recovery of Different Lipid Classes
Individual lipid classes of the extracted lipid were separated using thin-layer chromatography (TLC). Extracted
lipid from each tissue was diluted by hexane with BHT
such that 20 ll of solution contained around 2.5 mg of
lipid. Aliquots of 20 ll were spotted on a 20 9 20 cm
˚ analytical plate (500 lm layer) (Whatman
silica gel 60 A
Inc., Florham Park, NJ). Lipid class standards were also
spotted for detecting target bands. Total lipid classes were
separated by developing the plate in a solvent system
containing hexane, diethyl ether, and formic acid in the
ratio of 80:20:2 (v/v/v). The TLC plate was then sprayed
with 0.05 % primulin in acetone/water (8:2 v/v). Individual
lipid bands on the TLC plate were detected under a handheld UV lamp and the margins were marked with a pencil.
Target lipid classes bands were scraped from the TLC plate
using a small razor blade and collected into screw-capped
glass tubes. Recovered lipid classes from total lipid TLC
plate were PL, DG, FFA, TAG, and CE.
Fatty Acid Methyl Esters
Recovered lipid classes were transesteriﬁed into fatty acid
methyl esters (FAME) using the method of Curtis et al.

[16] with slight modiﬁcations. In each tube, 0.8 ml hexane
and 1.2 ml 10 % (v/v) acetyl chloride in methanol were
added. Tubes were capped, vortexed for 20 s, and placed in
an oven at 100 oC for 40 min. Upon completion of the
incubation period, samples were removed and allowed to
cool to room temperature. Then 2 ml of a 6 % sodium
carbonate solution and 0.4 ml hexane were added into each
tube. On subsequent vortexing and centrifuging of tubes
two distinct phases were obtained. The top organic layer
was removed and transferred to gas chromatography (GC)
vials. Solvent was evaporated under a nitrogen stream and
FAME were collected in 100 ll of hexane with BHT and
transferred to GC vial inserts. The samples were subsequently analyzed by GC using a GC2010 (Shimadzu Scientiﬁc Instruments, Columbia, MD).
GC Data Analysis
For each GC run, standard curves were generated using
commercially available FAME standards (Nu-Chek Prep,
Elysian, MN). To establish the linearity of the detector
response, a three-point calibration was generated with
every sample set. The calibration standard, GLC-463,
contained 42 fatty acids representing most of the common
species found in mammalian tissues and dairy products.
Chromatograms of sample FAME were compared with
those of FAME standards to identify target fatty acids. The
peak area for each fatty acid was then normalized to the
peak area and concentration of the corresponding surrogate
standard. Next, the molar concentration of the analytes was
calculated and then converted to moles of the corresponding lipid classes through molecular weight calculations. The molar concentration of lipid classes was
normalized to tissue sample weights to obtain concentrations (lmol/g tissue) in each tissue. Lastly, the mole percentage of each fatty acid species was calculated.
Gene Expression Analysis
Total RNA was extracted from liver, muscle, and adipose
tissue and prepared as previously described [10]. Microarray data were generated by Genome Quebec using the
Illumina platform (Illumina, Inc., San Diego, CA). Data
were analyzed using FlexArray 1.6, a custom statistical
software program developed by Genome Quebec [17]. The
expression data were ﬁltered to remove feature ids that
have not been detected. Next, a background adjustment and
normalization were carried out using the Lumi algorithm
(based on lumi Bioconductor package) in FlexArray 1.6.
Background correction was carried out by using negative
controls. Variance was stabilized by the variance-stabilizing transformation (VST) method and subsequently a
robust spline normalization was conducted. Analysis of

variance (ANOVA) was conducted to evaluate signiﬁcant
diet effects on gene expression across treatment groups.
The Cyber-T algorithm was employed to identify differentially regulated genes (CT gene lists) among tissues
between treatment groups from ANOVA gene lists [18]
followed by the Benjamini–Hochberg false discovery rate
multiple testing correction [19]. The CT gene lists were
then subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using ArrayTrack v.3.5.0
(NCTR/FDA) [20].
Real-Time PCR
Total RNA was extracted from liver samples using the
RNAeasy Mini-Kit (Qiagen, Valencia, CA). RNA quality
was checked and the concentration measured by NanoDrop
1000 (Thermo Fisher, Waltham, MA). RNA (1 lg) was
converted to cDNA using high-capacity cDNA reverse
transcription kit (Life Technologies, Carlsbad, CA). Validated and predesigned TaqMan primers and probes (Life
Technologies) were used to quantify cytochrome P450,
family 8, subfamily b, polypeptide 1 (Cyp8b1, ID:
Rn00579921_s1), 1-acylglycerol-3-phosphate O-acyltransferase 2 (Agpat2, ID: Rn01438505_m1), and angiopoietinlike 4 (Angptl4, ID: Rn01528817_m1). Beta-actin (Actb,
ID: ID Rn00667869_m1) was used as an endogenous
control. Real-time PCR ampliﬁcations were carried out in a
DNA Engine Opticon® 2 two-color real-time PCR detection system (Biorad, Hercules, CA). PCR results were
analyzed with the Opticon Monitor 3 software (Biorad).
The comparative Ct method was used to quantify gene
expression. DCt was obtained by normalizing to beta-actin.
DDCt was determined by the arithmetic formula described
by López-Parra et al. [21]. Symmetrical raw fold change
was obtained by comparing DDCt values of two groups
compared.
Liver Fat Analysis by Histology
Cryostat sections in 6 lm thickness were made from liver
samples taken out of -80 oC freezer. The tissue sections
were brought to room temperature on glass slides. The
slides were dipped a few times in 60 % triethyl phosphate
and then stained in 0.5 % Oil Red O (in 60 % triethyl
phosphate) for 15 min. After being rinsed in water for
2 min, the slides were counterstained in Harris modiﬁed
method hematoxylin stain (Thermo Fisher, Waltham, MA)
for 2 min. The slides were placed in saturated lithium
carbonate solution for 10 s, rinsed in water for 5 min, and
held in water. The slides were mounted with warm glycerin
jelly and observed with light microscopy. Color images
were captured with a digital camera attached to the
microscope. Lipids in randomly sampled areas from each

slide were quantiﬁed by ImageJ [22]. The fat content of
each sample was expressed by quantiﬁcation of Oil Red
O-stained areas as a percentage of whole area.
Liver Diacylglycerol Acyltransferase (DGAT)
Enzyme Assay
The microsomal fraction was obtained by the methods of Ko
et al. [23] and Coleman [24]. Rat liver (approximately 1.5 g)
was minced and then homogenized in 15 ml of STE buffer
(0.25 M sucrose, 10 mM Tris–HCl, pH 7.4, 1.0 mM EDTA)
with a Teﬂon-glass homogenizer at medium speed. The
homogenate was centrifuged at 14,0009g for 20 min at
4 oC. The supernatant was centrifuged at 100,0009g for 1 h
at 4 oC to obtain a microsomal pellet. The pellet was suspended in STE buffer without EDTA and centrifuged at
100,0009g for 1 h at 4 oC. The ﬁnal pellet was resuspended
in STE buffer without EDTA. Total protein in ﬁnal solution
was quantiﬁed by the Bradford assay. The microsomal fractions were stored in aliquots at -80 oC.
A ﬂuorescent DGAT assay was carried out as described
by McFie and Stone [25]. Brieﬂy, a master mix was prepared in a test tube containing 20 ll of 1 M Tris–HCl (pH
7.6), 4 ll of 1 M MgCl2, 10 ll of 4 mM dioleoyl-snglycerol, 10 ll of 12.5 mg/ml bovine serum albumin, 10 ll
of 500 lM NBD-palmitoyl CoA, and 96 ll of water
per reaction. Tubes were pre-incubated in a 37 oC water
bath for 2 min and 50 ll of protein sample was added to
start the reaction, which was held at 37 oC for 10 min with
occasional shaking. The reaction was terminated by addition of 4 ml CHCl3/MeOH (2:1, v/v). Samples were added
to 800 ll of water and allowed to sit at room temperature
for 1 h. Tubes were centrifuged at 3,0009g for 5 min to
separate aqueous and organic phases. The organic phase
was removed via pipette and dried under a stream of
nitrogen. Lipids were resuspended in 50 ll CHCl3/MeOH
(2:1) and spotted on a 20 9 20 cm TLC plate. TLC plates
were developed in the solvent system, hexane/diethyl ether/
acetic acid (80:20:1, v/v/v). The plates were air-dried for
1 h and scanned by Typhoon Trio ? Laser Imager 7 (GE
Healthcare, Waukesha, WI). The following settings were
used: excitation, blue (488 nm) LED laser light source;
emission, 520 nm BP emission ﬁlter. Fluorescence was
quantiﬁed by ImageJ [22]. The newly synthesized NBDTAG was quantiﬁed as units (ﬂuorescence intensity) of
NBD-TAG formed per minute per milligram of protein.
Statistical Analysis
A one-way ANOVA was performed using SAS software
version 9.2 (SAS Institute Inc.) to perform comparisons
among groups or using FlexArray 1.6 for gene expression
among groups and tissues. Group means were compared

using Cyber-T algorithm for gene expression data and
Ryan–Einot–Gabriel–Welsch multiple range test for other
data. Data were reported as mean ± standard deviation.

Fatty acid profile of red blood cells
35
abb

30

CO

Mole%

25

Results
Fatty Acid Proﬁle of Diets

AMF

baa

20

AMF-MFGM

15
abb

10

The most abundant fatty acids of the test diets are shown in
Fig. 1. Both the milk-fat-based diets have similar fatty acid
proﬁles, and are very different from the CO diet. The milk
fat diets both have signiﬁcant contributions of saturated
fatty acids (*65 %), whereas in the CO diet the percentage
is much lower (*17.5 %). All diets have similar levels of
monounsaturates, with oleic acid contributing approximately 25 %. The other notable difference is in the polyunsaturated fatty acid content (PUFA) content (CO 54 %,
AMF 4.5 %, and AMF-MFGM 6 %) and n-6/n-3 ratio (CO
54:1, AMF 6:1, AMF-MFGM 7:1).
Food Intake, Body Weight, Growth Rate, and Body Fat
Composition
There were no signiﬁcant differences in terms of food
intake, ﬁnal body weight, growth rate, or body fat composition (MRI analysis) among groups [10].
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Fig. 2 Red blood cell (RBC) fatty acids from rats fed CO (corn oil),
AMF (anhydrous milk fat), and AMF-MFGM (anhydrous milk fatmilk fat globule membrane). Only fatty acids signiﬁcantly different
across diet groups and present at [1 % of total fatty acids are shown.
Means in a row with different superscripts are signiﬁcantly different
(p \ 0.05)

the CO cohort had a higher percentage of 18:2n-6, 20:4n-6, and
22:4n-6, all n-6 fatty acids, presumably because of the high
linoleic acid content of the diet. In addition, these animals had
lower percentages of 16:1n-7, 18:1n-9, 18:1n-7, 20:3n-9,
20:5n-3, 22:5n-3, and 22:6n-3 compared to the animals fed the
milk fat diets. The RBC from animals fed the two milk-fatbased diets had remarkably similar fatty acid proﬁles with two
statistically relevant differences. Namely, the AMF-MFGMfed animals had a higher percentage of 18:1n-7 and a lower
percentage of 20:3n-9.

Fatty Acids Proﬁle of Red Blood Cells
The red blood cell (RBC) fatty acid proﬁle was measured to
compare the CO diet to the milk-fat-based diets, and to
determine if the higher polar lipid content of the AMF-MFGM
had an effect compared with the AMF diet. RBC fatty acids
that were signiﬁcantly affected by the diets and present at
[1 % of total fatty acids are shown in Fig. 2. Not surprisingly,
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As with the RBC, there were large differences between the
fatty acid proﬁle in skeletal muscle and visceral adipose
tissue of the rats fed the CO diet versus the milk fat diets
which were virtually identical. In skeletal muscle, the COfed animals had signiﬁcantly less 16:1n-7, 18:1n-9, and
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among the major fatty acids ([1 % total), the CO animals
had less 16:0, 16:1n-7, 18:0, and 18:1n-9 and more 18:2n6. The only fatty acid that differed among the animals fed
the milk fat diets was 20:3n9, which in both tissues was
slightly lower in the AMF-MFGM group.
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Fig. 1 Fatty acid proﬁle of experimental diets. Only fatty acids
signiﬁcantly different across groups and present at [1 % of total fatty
acids are shown. Means in a row with different superscripts are
signiﬁcantly different (p \ 0.05)

Fatty acids in liver tissue which were signiﬁcantly affected by
the CO, AMF, and AMF-MFGM diets and which contribute
[1 % of fatty acids in one tissue are presented in Fig. 5.
Animals from the CO group had less 16:1n-7, 18:1n-9, 20:3n9, and 22:6n-3 and more 18:2n-6 and 20:4n-6. Unlike the
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Fig. 3 Fatty acid proﬁle of skeletal muscle from rats fed CO (corn
oil), AMF (anhydrous milk fat), and AMF-MFGM (anhydrous milk
fat–milk fat globule membrane). Only fatty acids signiﬁcantly
different across diet groups and present at [1 % of total fatty acids
are shown. Means in a row with different superscripts are signiﬁcantly
different (p \ 0.05)
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Fig. 4 Fatty acid proﬁle of visceral adipose tissue from rats fed CO
(corn oil), AMF (anhydrous milk fat), and AMF-MFGM (anhydrous
milk fat–milk fat globule membrane). Only fatty acids signiﬁcantly
different across diet groups and present at [1 % of total fatty acids
are shown. Means in a row with different superscripts are signiﬁcantly
different (p \ 0.05)

RBC, skeletal muscle, and adipose tissues, supplementation
of the AMF diet with MFGM results in several differences in
the fatty acid proﬁle of the liver. For example, of the six fatty
acids which are signiﬁcantly affected across the diets and
present at[1 %, ﬁve are signiﬁcantly different in livers of the
animals fed the AMF and AMF-MFGM diets. Thus, the
increased polar lipid concentration of the AMF-MFGM diet
appears to have signiﬁcant effects on liver lipid metabolism
and partitioning. The largest differences are in 18:1n-9, which
is higher in the AMF animals, and 20:4n-6 and 22:6n-3 which
are higher in the AMF-MFGM cohort.
Plasma, Visceral Adipose, and Liver Lipid Classes
To better understand the differences in lipid partitioning as
affected by the CO, AMF, and AMF-MFGM diets, plasma
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Fig. 5 Fatty acid proﬁle of liver tissue from rats fed CO (corn oil),
AMF (anhydrous milk fat), and AMF-MFGM (anhydrous milk fatmilk fat globule membrane). Only fatty acids signiﬁcantly different
across diet groups and present at [1 % of total fatty acids are shown.
Means in a row with different superscripts are signiﬁcantly different
(p \ 0.05)

adipose and liver lipid classes were analyzed and classes
with signiﬁcant differences are shown in Fig. 6. Interestingly, the animals consuming AMF as the fat source had
less total PL in plasma than animals fed the CO and AMFMFGM diets. Additionally, there was less TAG than the
animals fed the AMF-MFGM diet. In the visceral adipose,
there was more TAG in the animals fed CO than those fed
the AMF-MFGM. In the liver, there was more FFA in the
animals fed the CO diet than in those fed the AMF-MFGM
diet, and a similar trend for the AMF animals, although this
was not signiﬁcant. On the other hand, the CO diet resulted
in less accumulated TAG than the AMF diet, with the
AMF-MFGM diet in between. Lastly, both the CO and the
AMF-MFGM diets resulted in lower hepatic CE than did
the AMF diet.
Tissue Gene Expression
In total, 293, 1,124, and 831 genes were found to be differentially expressed respectively in skeletal muscle, adipose, and liver at p \ 0.05. To identify metabolic pathways
that were affected across the three diets all the genes that
were differentially regulated according to the ANOVA
were analyzed with the program ArrayTrack, a free software tool developed by the National Center for Toxicological Research (NCTR) and the US Food and Drug
Administration (FDA). All three diets were compared and
the data generated from this analysis are summarized in
Table 1. On a diet comparison basis, the fewest number of
pathways affected across the three tissues were between the
two milk-fat-fed animal groups (22 pathways) and the most
pathways were affected between the CO and AMF-MFGM
groups (40). In speciﬁc tissues, there were 18 pathways
differentially affected in skeletal muscle, 31 in adipose, and

Fig. 6 Quantitative analysis
of lipid classes from
plasma, visceral adipose,
and liver. PL phospholipids,
TAG triacylglycerols,
FFA free fatty acids,
CE cholesteryl esters. Means in
a row with different superscripts
are signiﬁcantly different
(p \ 0.05)

40 in the liver. In speciﬁc diet/tissue comparisons, the
fewest number of pathways were affected in skeletal
muscle between the CO and the AMF diets (2). There
were 16 pathways affected between the AMF and CO
diets in the liver and 16 pathways between the AMFMFGM and CO diets in adipose. In the lower half of
Table 1 the pathways that were signiﬁcantly affected
across at least two diet combinations are shown. For
example, in the muscle tissue, the circadian rhythm
pathway (KEGG rno 04710) was signiﬁcantly affected
between all three diets, whereas adipocytokine signaling
(rno00020) was only affected in the diet combinations in
which AMF was compared. Similar to the fatty acid data
of the selected tissues, there were fewer pathways
affected in the muscle and adipose tissue compared to
the liver. A striking feature of the pathway analysis
shown in the bottom half of Table 1 is that only three
pathways were different in the liver between the two
milk fat diets, whereas [10 were affected when these
diets were compared to the CO diet.
Although the two milk fat diets were nearly identical
at the fatty acid level, there were several differences in
the liver and plasma lipid proﬁles of the rats fed the
AMF and AMF-MFGM diets. Therefore, the expression
of several genes of interest was determined using RTPCR and the results are shown in Table 2. The three
genes selected were chosen from the KEGG pathways
differentially affected by the milk fat diets in Table 1.
The results of the RT-PCR in Table 2 are expressed
relative to b-actin, and thus a smaller number indicates a
higher expression level. Comparing the two milk fat
groups, all three genes are more highly expressed in the
livers of the AMF-MFGM rats compared to the AMF
group.

Liver Fat Analysis by Histology and DGAT Assay
In general, both the lipid analysis and the gene expression
proﬁling indicated that the diets had the greatest effect on
the liver. Although there was not a quantitative difference
in the fatty acid content of the livers, there were signiﬁcant
differences in distributions across lipid classes (Fig. 6). For
example, there is more triacylglycerol in the livers of rats
fed AMF compared to the CO, yet the total fatty acid was
not different. Interestingly, expression of diacylglycerol
O-acylransferase 2 (DGAT2), was lower in the CO-fed
animals than in the other two groups. Consequently, the
livers were stained with Oil Red O and DGAT activity was
measured via enzymatic assay of the microsomal fraction,
and the results are shown in Fig. 7. There was signiﬁcantly
less staining of the hepatic tissue of the CO-fed rat
(Fig. 7a), and this corresponded with lower DGAT activity
(Fig. 7b).

Discussion
The main focus of this work was to utilize tissue fatty acid
proﬁling and transcriptomics to determine the effects of
changing the lipid source of the AIN-76A diet on lipid
metabolism. This work was conducted on key tissues
involved in lipid metabolism, storage, and processing
(skeletal muscle, visceral adipose, and liver) as well as
plasma. The fat sources used in formulating the diets (corn
oil, anhydrous milk fat, and anhydrous milk fat supplemented with milk fat globule membrane) were originally
selected for an ACF study previously reported [10]. In that
study, as in most ACF studies, the CO diet was selected as
a control, whereas the AMF-MFGM diet was included to

Table 1 Metabolic pathways signiﬁcantly affected across all three diet combinations
Tissue

Diets
Number of pathways affected
AMF versus CO

Muscle
Adipose

AMF-MFGM versus CO

2

11

AMF-MFGM versus AMF

All

5

18

9

16

6

31

Liver

16

13

11

40

All

27

40

22

KEGG pathway

AMF versus CO

AMF-MFGM versus CO

Circadian rhythm (rno04710)

H

H

PPAR signaling (rno03320)

H

AMF-MFGM versus AMF

Muscle
H
H
H

Adipocytokine signaling (rno04920)

H

Adipose
Circadian rhythm (rno04710)

H

H

H

Endocytosis (rno04710)

H

H

H

Butanoate metabolism (rno00650)

H

H

H

Citrate cycle (TCA cycle) (rno00020)

H

H

Liver
PPAR signaling (rno03320)

H

H

H

C21 steroid hormone metabolism (rno00140)

H

H

H

Biosynthesis of unsaturated fatty acids (rno01040)

H

H

Retinol metabolism (rno00830)

H

H

Starch and sucrose metabolism (rno00500)

H

H

Pyruvate metabolism (rno00620)

H

H

Galactose metabolism (rno00052)

H

H

Insulin signaling pathway (rno04910)

H

H

Maturity onset diabetes of the young (rno04950)

H

H

Androgen and estrogen metabolism (rno00150)

H

H
H

Glycerophospholipid metabolism (rno00564)

H

CO corn oil, AMF anhydrous milk fat, AMF-MFGM anhydrous milk fat–milk fat globule membrane

Table 2 Differentially expressed genes by ANOVA in liver from rats
fed with diet containing corn oil (control), anhydrous milk fat (AMF),
and milk fat globule membrane (AMF-MFGM) (unit: DDC(t))

Table 3 Percentage of 20:3n-9 in highly unsaturated fatty acids
(HUFA) in RBC, skeletal muscle, adipose, and liver as a function of
diet

Genes

CO

%20:3n-9 in HUFA

Corn oil

Cyp8b1

-0.94 ± 0.75b

-0.10 ± 0.50a

-2.49 ± 0.93c

RBC

NDb

Agpat2

1.93 ± 2.36

2.82 ± 1.14

1.14 ± 1.03

Muscle

Angptl4

2.90 ± 2.10

4.19 ± 0.99

2.34 ± 1.36

Adipose
Liver

AMF

ab
b

MFGM

a
a

b
b

a–c

Means in a row with different superscripts are signiﬁcantly different (p \ 0.05)

AMF

AMF-MFGM

11.05 ± 0.26a

8.60 ± 2.40a

0.51 ± 0.08

20.01 ± 0.45

a

12.44 ± 0.28b

7.92 ± 0.41
0.53 ± 0.05c

43.08 ± 2.37
15.65 ± 1.67a

31.40 ± 0.37b
8.64 ± 1.15b

c
c

a

ND not detected
a–c

Means in a row with different superscripts are signiﬁcantly different (p \ 0.05)

determine potential cancer protective effects of speciﬁc
lipids associated with this material, such as sphingomyelin
and plasmalogens. The AMF diet was included to control

for the potential for other lipids in milk fat to affect the
development of ACF, such as butyrate and conjugated
linoleic acid.

Fig. 7 Hepatic Oil Red staining
(a) and hepatic DGAT activity
(b) in liver tissue from rats fed
CO (corn oil), AMF (anhydrous
milk fat), and AMF-MFGM
(anhydrous milk fat–milk fat
globule membrane). Means with
different superscripts are
signiﬁcantly different (p \ 0.05)

The membrane composition of RBC reﬂects dietary fat
sources, and several groups have investigated the correlation of RBC fatty acid proﬁles with disease susceptibility in
humans. For example, Harris and Von Schacky [26]
showed that the omega-3 index, the combined percentage
of EPA (20:5n-3) and DHA (22:6n-3) in RBC, correlates
with the risk of coronary heart disease (CHD) in humans
with values above 8 % being associated with the most
protection and values below 4 % with the least. A similar
metric, the percent contribution of omega-6 fatty acids to
highly unsaturated fatty acids (% n-6 HUFA), was shown
by Lands [27] to correlate with CHD mortality in several
human populations with levels below 40 % being protective. The omega-3 indices were 0.9 for the CO diet, 2.5 for
the AMF diet, and 2.0 for the AMF-MFGM diet, whereas
the % n-6 HUFA levels were 96, 79, and 83 %, respectively. Although these metrics may not be applicable in
rodents, it is interesting nonetheless that all three diets
result in very low levels of n-3 long chain PUFA in RBC
which likely affect many physiological processes.
One interesting fatty acid which is present at signiﬁcant
levels in the RBC, muscle, adipose, and liver of the milkfat-fed animals, but not those consuming CO, is 20:3n-9.
This fatty acid is an elongation product of oleic acid and
has been shown to be a sensitive marker of PUFA intake.
According to Lands [27], 20:3n-9 correlates with low
PUFA intakes and a value of approximately 10 % in the
HUFA indicates PUFA insufﬁciency. To our knowledge,
no studies have provided data on the percentage contribution of 20:3n-9 to tissue HUFA for RBC, muscle, adipose,
and liver which are shown in Table 3. Animals fed the
AMF diet have the highest levels of this fatty acid across
all tissues measured, whereas those consuming the AMFMFGM diets also had high levels. Interestingly, the HUFA
percentage of 20:3n-9 in adipose was high for the CO-fed
animals, albeit not as high as the other groups. This may be
a result of the very low concentration of HUFA in adipose,
as the lipids in this tissue are primarily less than 18 carbons
in length.
The lipid proﬁles of the RBC, muscle, adipose, and liver
reﬂect the fat sources of the three diets, and there were few
differences between those fed the AMF and AMF-MFGM.

However, there were quantitative differences across lipid
classes in both plasma and the liver. Pathway analysis of
the gene expression data indicated that the fewest pathways
were affected in skeletal muscle and the most in liver.
There were no differences in total liver fatty acids between
treatments, but there was in the distribution of fatty acid
across lipid classes (Fig. 6). One striking feature is the high
FFA and low TAG in the livers of the CO-fed rats compared to those fed the AMF-MFGM diet. To further
investigate this ﬁnding we compared Oil Red O staining in
livers across the three treatments, and the results are shown
in Fig. 7a. In the rats fed the CO diets there is less Oil Red
O staining. According to O’Rourke et al. [28] Oil Red O
staining of tissues is well correlated with triglyceride
content. The inverse relationship between the hepatic TAG
and FFA suggests that the differences may be due to triglyceride synthesis activity. According to the gene
expression proﬁling, DGAT2, the enzyme responsible for
the ﬁnal step in TAG synthesis from diacylglycerols and
FFA was 1.25-fold lower in the CO-fed rats compared to
those fed AMF and 1.46-fold lower compared to those fed
AMF-MFGM. These differences are modest, and it was not
clear if their expression would translate into physiological
differences. Thus, the triacylglycerol synthetic activity in
liver microsomal fractions was measured using a functional
assay and the results are shown in Fig. 7b. In agreement
with the Oil Red O staining, the DAG activity measure
suggests that the differences in FFA, DAG, and TAG levels
in the liver may be partially explained by the conversion of
FFA and DAG into TAG.
Although excess hepatic TAG storage has typically been
viewed as a negative physiological response, it may be
protective under some metabolic situations. For example,
in a mouse model of nonalcoholic steatohepatitis (NASH),
Yamaguchi et al. [29] evaluated the effects of hepatic
DGAT2 expression on disease development using an
antisense nucleotide treatment. Although reducing expression of DGAT2 did prevent hepatic steatosis, the increase
in FFA was associated with markers of lipid peroxidation/
oxidant stress and ﬁbrosis. From this study the authors
concluded that accumulation of hepatic TAG is actually
protective against progressive liver damage in NAFLD. It

is unclear why the CO diet resulted in lower DGAT
expression and activity in the CO-fed rats. However, one
distinguishing feature of this diet is the PUFA content
primarily in the form of linoleic acid. Interestingly,
reviewing the fatty acid composition of diets used to study
NASH, Romestaing et al. [30] drew the conclusion that
dietary PUFA with a high omega-6 to omega-3 ratio may
be a causative factor via effects on lipid peroxidation and
proinﬂammatory cytokine production.
There are several differences in the plasma and hepatic
lipid proﬁles of the animals fed the two milk fat diets which
is surprising considering the similarity of these diets at the
fatty acid level. According to the KEGG pathway analysis
conducted on the hepatic gene expression and shown in
Table 1, the two milk fat diets affected PPAR signaling
(rno03320), C21 steroid hormone metabolism (rno00140),
and glycerophospholipid metabolism (rno00564). The
affected PPAR signaling in both the liver and skeletal
muscle was mediated through PPARa receptors. The
involved genes were associated with lipogenesis, cholesterol metabolism, and fatty acid transport in the liver and
with lipogenesis in skeletal muscle. Consequently, the
expression of three genes from these pathways was validated using RT-PCR. The genes Cyp8b1, Agpat2, and
Angptl4 were selected from the differentially expressed
genes in the pathways determined by the gene expression
proﬁling. They were chosen owing to their physiological
function and potential to affect tissue lipid partitioning, and
the results are shown in Table 2. The function of these
genes is discussed below including their potential roles in
affecting lipid metabolism across the two milk fat groups.
Of course these ﬁndings are only correlations and positive
conﬁrmation of their roles will need to be tested explicitly
for conﬁrmation.
Cyp8b1 is a cytochrome P450 enzyme which is a
component of the primary bile acid biosynthesis and
PPARa signaling pathways in the liver. Cyp8b1 is involved
in the synthesis of cholic acid [31]. Cyp8b1 controls the
ratio of cholic acid to chenodeoxycholic acid in bile salts,
and as cholic acid is less effective in solubilizing cholesterol it may affect its absorption [32]. The AMF-MFGM
diet was associated with a lower hepatic cholesteryl ester
content (Fig. 6). Milk polar lipids affect both the absorption and fecal excretion of cholesterol when fed both
acutely and chronically. For example, Noh and Koo [33]
found that infusion of milk sphigomyelin via a duodenal
catheter resulted in decreased cholesterol, fat, and vitamin
E absorption. In a chronic feeding study, Kamili et al. [34]
fed mice high-fat diets for 5 weeks; the diets were supplemented with two different formulations of milk phospholipids at 1.2 % by weight. Both milk polar lipid
preparations resulted in signiﬁcant decreases in liver cholesterol and triglyceride which was accompanied by an

increase in fecal cholesterol excretion. Data from the
present study indicate that the decreased cholesterol
absorption and increased fecal excretion resulting from
luminal milk polar lipids in those previous studies may be
mediated, at least in part, by the ratio of bile acids.
Agpat2 is an enzyme responsible for the conversion of
lysophosphatidic acid to phosphatidic acid, a step in PL
synthesis, and is a component of KEGG pathway glycerophospholipid metabolism. The expression of Agpat2 was
higher in the AMF-MFGM group than the AMF group
(Table 2) but there was not a signiﬁcant difference in
hepatic PL. There was, on the other hand, a signiﬁcant
increase in plasma PL in the AMF-MFGM group. The
increased plasma PL may result from increased hepatic
synthesis and secretion. Previous studies with milk polar
lipids have also shown the ability of these constituents to
increase both plasma PL and TAG. For example, Wat et al.
[35] fed mice both a low-fat, non-puriﬁed diet and a highfat diet formulated with and without a 2.5 % PL-rich milk
fat extract. In the mice fed the low-fat, non-puriﬁed diet,
the milk PL increased the plasma TAG by 20 % and the
plasma PL by 5 % compared with values in the control
mice fed the low-fat diet. However, in the mice fed the
high-fat diets, the PL-rich extract actually reduced both the
plasma TAG and PL to levels similar to the low-fat control.
The increased plasma lipid concentration in the rats fed the
AMF-MFGM diet, compared to those fed the AMF diet,
may be a result of either more lipid exported from the liver,
or from reduced clearance via peripheral tissues.
Expression of Angptl4 was also veriﬁed by RT-PCR.
Angptl4 is a component of the PPARa signaling pathway.
It is an angiopoietin-like protein which increases plasma
TAG via suppression of lipoprotein lipase [36]. Interestingly, there were signiﬁcant differences in plasma TAG
between the two milk-fat-fed groups (Fig. 6). Also known
as fasting-induced adipocyte factor (Fiaf), Angptl4 is
highly expressed in the gut epithelium in germ-free mice
and prevents accumulation of fat into adipocytes, whereas
conventionalization with a microﬂora suppresses this effect
[37]. Although it is not clear if hepatic expression of
Angptl4 in the AMF-MFGM-fed rats contributed to the
increase in plasma TAG, this ﬁnding indicates a potential
mechanism via which this effect was mediated.
Despite the fact that it is still commonly used in ACF
studies with rodents [7], the high sucrose content of the
AIN-76A diet has been long known to cause fatty liver in
animals fed the diet for long periods of time [9]. Therefore,
when reviewing the different effects of the fat sources on
tissue lipid composition and gene expression it is necessary
to keep in mind that these changes are in the context of an
overall metabolically stressful diet. From the data presented here, a few hypotheses may be drawn that can be
tested in studies designed speciﬁcally for their evaluation.

For example, compared to the milk fat diets, the CO diet
caused a signiﬁcant increase in hepatic free fatty acids, a
potential trigger for the development of NASH from NAFLD.
Conversely, compared to the CO and AMF-MFGM diets, the
AMF diet resulted in more hepatic TAG storage which in
itself may be undesirable. Supplementing the AMF diet with
polar lipids from milk appears to reduce the accumulation of
hepatic TAG yet appears to achieve this effect via promotion
of lipid export into plasma. The long-term physiological
signiﬁcance of this is unknown. In conclusion, the fat source
of the AIN-76A diet affects the tissue proﬁle of key tissues
involved in lipid trafﬁcking and storage as well as gene
expression networks within these tissues.
Acknowledgments This study was supported by both a seed grant
from the Center for Integrated Biosystems at Utah State University
and by the Utah Agricultural Experiment Station and was approved as
journal paper number 8290. We are grateful to Dallin Snow for
preparing RNA samples for Microarray analysis and Dr. Aaron Olsen
and Kent Udy for assistance with animal studies.

References
1. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 puriﬁed
diets for laboratory rodents: ﬁnal report of the American Institute
of Nutrition ad hoc writing committee on the reformulation of the
AIN-76A rodent diet. J Nutr 123(11):1939–1951
2. Roebuck BD, Wilpone SA, Fiﬁeld DS, Yager JD Jr (1979)
Hemorrhagic deaths with AIN-76 diet. J Nutr 109(5):924–925
3. Nguyen HT, Woodard JC (1980) Intranephronic calculosis in
rats: an ultrastructural study. Am J Pathol 100(1):39–56
4. Medinsky MA, Popp JA, Hamm TE, Dent JG (1982) Development of hepatic lesions in male Fischer-344 rats fed AIN-76A
puriﬁed diet. Toxicol Appl Pharmacol 62(1):111–120
5. Nutrition A (1980) Second report of the ad hoc committee on
standards for nutritional studies. J Nutr 110:1726
6. Council NR (1995) Nutrient requirements of laboratory animals,
vol 4th Revised. National Academy Press, Washington, p 172
7. Corpet DE, Tache S (2002) Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt
foci and tumor data, ranked by potency. Nutr Cancer 43(1):1–21
8. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular
disease in patients with nonalcoholic fatty liver disease. N Engl J
Med 363(14):1341–1350
9. Bacon BR, Park CH, Fowell EM, McLaren CE (1984) Hepatic
steatosis in rats fed diets with varying concentrations of sucrose.
Fundam Appl Toxicol 4(5):819–826
10. Snow DR, Jimenez-Flores R, Ward RE, Cambell J, Young MJ,
Nemere I, Hintze KJ (2010) Dietary milk fat globule membrane
reduces the incidence of aberrant crypt foci in Fischer-344 rats.
J Agric Food Chem 58(4):2157–2163
11. Jensen RG (1995) Handbook of milk composition: food science
and technology international series. Academic, San Diego, p 919
12. Mcpherson AV, Dash MC, Kitchen BJ (1984) Isolation of bovinemilk fat globule-membrane material from cream without prior
removal of caseins and whey proteins. J Dairy Res 51(1):113–121
13. MacGibbon A, Taylor M (2006) Composition and structure of
bovine milk lipids. In: Fox PF, McSweeney PLH (eds) Advanced
dairy chemistry. Springer, New York, pp 1–42
14. Spitsberg VL (2005) Invited review: bovine milk fat globule
membrane as a potential nutraceutical. J Dairy Sci 88:2289–2294

15. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for
the isolation and puriﬁcation of total lipides from animal tissues.
J Biol Chem 226(1):497–509
16. Curtis JM, Berrigan N, Dauphinee P (2008) The determination of
n-3 fatty acid levels in food products containing microencapsulated ﬁsh oil using the one-step extraction method. Part 1: measurement in the raw ingredient and in dry powdered foods. J Am
Oil Chem Soc 85(4):297–305
17. Blazejczyk M, Miron M, Nadon R (2007) FlexArray: a statistical
data analysis software for gene expression microarrays.
http://genomequebec.mcgill.ca/FlexArray. Accessed 8 Oct 2012
18. Long AD, Mangalam HJ, Chan BY, Tolleri L, Hatﬁeld GW,
Baldi P (2001) Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical
framework: analysis of global gene expression in Escherichia coli
K12. J Biol Chem 276(23):19937–19944
19. Hochberg Y, Benjamini Y (1990) More powerful procedures for
multiple signiﬁcance testing. Stat Med 9(7):811–818
20. Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A,
Hong H, Xie Q, Perkins R, Shi L, Casciano D (2003) ArrayTrack–supporting toxicogenomic research at the US Food and
Drug Administration National Center for Toxicological Research.
Environ Health Perspect 111(15):1819–1826
21. Lopez-Parra M, Titos E, Horrillo R, Ferre N, Gonzalez-Periz A,
Martinez-Clemente M, Planaguma A, Masferrer J, Arroyo V, Claria
J (2008) Regulatory effects of arachidonate 5-lipoxygenase on
hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. J Lipid Res
49(12):2513–2523
22. Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image processing
with ImageJ. Biophotonics Int 11(7):36–42
23. Ko JS, Ryu SY, Kim YS, Chung MY, Kang JS, Rho MC, Lee HS,
Kim YK (2002) Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Arch
Pharm Res 25(4):446–448
24. Coleman RA (1992) Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine. Methods
Enzymol 209:98–104
25. McFie PJ, Stone SJ (2011) A ﬂuorescent assay to quantitatively
measure in vitro acyl CoA:diacylglycerol acyltransferase activity.
J Lipid Res 52(9):1760–1764
26. Harris WS, Von Schacky C (2004) The omega-3 index: a new risk
factor for death from coronary heart disease? Prev Med
39(1):212–220
27. Lands B (2008) A critique of paradoxes in current advice on
dietary lipids. Prog Lipid Res 47(2):77–106
28. O’Rourke EJ, Soukas AA, Carr CE, Ruvkun G (2009) C. elegans
major fats are stored in vesicles distinct from lysosome-related
organelles. Cell Metab 10(5):430–435
29. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK,
Bhanot S, Monia BP, Li YX, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates
liver damage and ﬁbrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45(6):1366–1374
30. Romestaing C, Piquet MA, Bedu E, Rouleau V, Dautresme M,
Hourmand-Ollivier I, Filippi C, Duchamp C, Sibille B (2007)
Long term highly saturated fat diet does not induce NASH in
Wistar rats. Nutr Metab (Lond) 4:4
31. Li-Hawkins J, Gafvels M, Olin M, Lund EG, Andersson U,
Schuster G, Bjorkhem I, Russell DW, Eggertsen G (2002) Cholic
acid mediates negative feedback regulation of bile acid synthesis
in mice. J Clin Invest 110(8):1191–1200
32. Gafvels M, Olin M, Chowdhary BP, Raudsepp T, Andersson
U, Persson B, Jansson M, Bjorkhem I, Eggertsen G (1999)
Structure and chromosomal assignment of the sterol 12alphahydroxylase gene (CYP8B1) in human and mouse: eukaryotic

cytochrome P-450 gene devoid of introns. Genomics
56(2):184–196
33. Noh SK, Koo SI (2004) Milk sphingomyelin is more effective
than egg sphingomyelin in inhibiting intestinal absorption of
cholesterol and fat in rats. J Nutr 134(10):2611–2616
34. Kamili A, Wat E, Chung RW, Tandy S, Weir JM, Meikle PJ,
Cohn JS (2010) Hepatic accumulation of intestinal cholesterol is
decreased and fecal cholesterol excretion is increased in mice fed
a high-fat diet supplemented with milk phospholipids. Nutr
Metab (Lond) 7:90

35. Wat E, Tandy S, Kapera E, Kamili A, Chung RW, Brown A,
Rowney M, Cohn JS (2009) Dietary phospholipid-rich dairy milk
extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 205(1):144–150
36. Kersten S (2005) Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33(Pt 5):1059–1062
37. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A,
Semenkovich CF, Gordon JI (2004) The gut microbiota as an
environmental factor that regulates fat storage. Proc Natl Acad
Sci U S A 101(44):15718–15723

